Simdax Innrennslisþykkni, lausn 2,5 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

simdax innrennslisþykkni, lausn 2,5 mg/ml

orion corporation - levosimendanum inn - innrennslisþykkni, lausn - 2,5 mg/ml

Vetmedin vet. (Pimovita) Tuggutafla 1,25 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vetmedin vet. (pimovita) tuggutafla 1,25 mg

boehringer ingelheim vetmedica gmbh* - pimobendanum inn - tuggutafla - 1,25 mg

Vetmedin vet. (Pimovita) Tuggutafla 10 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vetmedin vet. (pimovita) tuggutafla 10 mg

boehringer ingelheim vetmedica gmbh* - pimobendanum inn - tuggutafla - 10 mg

Vetmedin vet. (Pimovita) Tuggutafla 5 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

vetmedin vet. (pimovita) tuggutafla 5 mg

boehringer ingelheim vetmedica gmbh* - pimobendanum inn - tuggutafla - 5 mg

Genestran Vet Stungulyf, lausn 75 míkróg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

genestran vet stungulyf, lausn 75 míkróg/ml

animedica gmbh* - cloprostenolum natríum - stungulyf, lausn - 75 míkróg/ml

Menbutil (Genabiline) Stungulyf, lausn 100 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

menbutil (genabiline) stungulyf, lausn 100 mg/ml

animedica gmbh - menbutone - stungulyf, lausn - 100 mg/ml

Morphasol vet Stungulyf, lausn 4 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

morphasol vet stungulyf, lausn 4 mg/ml

animedica gmbh* - butorphanolum tartrat - stungulyf, lausn - 4 mg/ml

Procapen vet Spenalyf, dreifa 3 g Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

procapen vet spenalyf, dreifa 3 g

animedica gmbh* - benzylpenicillinprocainum - spenalyf, dreifa - 3 g

Torphasol vet (Morphasol) Stungulyf, lausn 10 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

torphasol vet (morphasol) stungulyf, lausn 10 mg/ml

animedica gmbh* - butorphanolum tartrat - stungulyf, lausn - 10 mg/ml

Sutent Evrópusambandið - íslenska - EMA (European Medicines Agency)

sutent

pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - Æxlishemjandi lyf - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.